HomeTRVI • NASDAQ
add
Trevi Therapeutics Inc
Previous close
$6.19
Day range
$6.19 - $6.70
Year range
$2.30 - $7.39
Market cap
661.34M USD
Avg Volume
1.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.47M | -3.66% |
Net income | -10.34M | 5.16% |
Net profit margin | — | — |
Earnings per share | -0.09 | 18.18% |
EBITDA | -11.43M | 3.69% |
Effective tax rate | 0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.26M | 41.80% |
Total assets | 107.00M | 36.21% |
Total liabilities | 7.55M | 21.24% |
Total equity | 99.46M | — |
Shares outstanding | 101.74M | — |
Price to book | 6.19 | — |
Return on assets | -26.32% | — |
Return on capital | -28.52% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.34M | 5.16% |
Cash from operations | -13.48M | -28.76% |
Cash from investing | -9.95M | -22.99% |
Cash from financing | 8.70M | 31,189.29% |
Net change in cash | -14.72M | 20.78% |
Free cash flow | -10.12M | -52.85% |
About
Founded
2011
Headquarters
Website
Employees
31
